Galecto, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
GLTO Nasdaq 2834 galecto.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Galecto, Inc.

Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones - Jan 12th, 2026 6:00 am
Wayfair upgraded, Instacart initiated: Wall Street's top analyst calls - Jan 7th, 2026 7:41 am
Galecto Announces Key Additions to Leadership Team - Jan 6th, 2026 6:00 am
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Dec 16th, 2025 3:00 pm
Metagenomi, Ovid CEOs step aside; Cogent soars on ‘unprecedented’ stomach cancer data - Nov 12th, 2025 3:20 am
This Penny Stock Just Quadrupled. Should You Buy It Now? - Nov 10th, 2025 2:05 pm
Galecto Announces Acquisition of Damora Therapeutics - Nov 10th, 2025 5:00 am
Galecto Reports Third Quarter 2025 Operating and Financial Results - Nov 6th, 2025 2:30 pm
Galecto to Highlight GB3226 Program at ASH 2025 - Nov 3rd, 2025 7:00 am
This Penny Stock Just Jumped 750%. Can It Retain These Gains for the Long Term? - Oct 7th, 2025 2:43 pm
Galecto Reports Second Quarter 2025 Operating and Financial Results - Aug 5th, 2025 2:15 pm
Galecto Reports First Quarter 2025 Operating and Financial Results - May 8th, 2025 2:30 pm
Galecto Reports Full-Year 2024 Financial Results - Mar 19th, 2025 2:45 pm
Galecto to Participate in Upcoming Investor Conferences - Feb 6th, 2025 6:00 am